Thiebaut F, Tsuruo T, Hamada H, Gottesman M M, Pastan I, Willingham M C
Laboratory of Molecular Biology, National Cancer Institute, Bethesda, Maryland 20892.
J Histochem Cytochem. 1989 Feb;37(2):159-64. doi: 10.1177/37.2.2463300.
Using peroxidase immunohistochemistry, we examined the distribution of P170, a multidrug transport protein, in normal tissues by use of two different monoclonal antibodies (MAb). MAb MRK16 is a MAb that has been shown to react with an epitope in P170 located on the external face of the plasma membrane of multidrug-resistant human cells. MAb C219 has been shown to react with P170 in many mammalian species, and detects an epitope located on the cytoplasmic face of the plasma membrane. Using MRK16, we have previously described the localization of P170 on the bile canalicular face of hepatocytes, the apical surface of proximal tubular cells in kidney, and the surface epithelium in the lower GI tract in normal human tissues. In this work, we report that MRK16 also detects P170 in the capillaries of some human brain samples. A similar pattern was found using MAb C219 in rat tissues. in addition, MAb C219 showed intense localization in selected skeletal muscle fibers and all cardiac muscle fibers in rat and human tissues. ATPase cytochemistry showed that these reactive skeletal muscle fibers were of the type I (slow-twitch) class. Other additional sites of C219 reactivity in rat tissues were found in pancreatic acini, seminal vesicle, and testis. Electrophoretic gel immunoblotting showed two protein bands reactive with MAb C219. In liver, MAb C219 reacted with a approximately 170 KD band. In skeletal and cardiac muscle, MAb C219 reacted with a approximately 200 KD band which migrated in the same position as myosin. This band also reacted with an antibody to skeletal muscle myosin. This result suggests that C219 may crossreact with the heavy chain of muscle myosin in cardiac and skeletal muscle. Because MAb C219 reacts with proteins other than P170, it should be used with caution in studies of multidrug resistance.
利用过氧化物酶免疫组织化学方法,我们使用两种不同的单克隆抗体(MAb)检测了多药转运蛋白P170在正常组织中的分布。单克隆抗体MRK16已被证明能与多药耐药人类细胞质膜外表面P170上的一个表位发生反应。单克隆抗体C219已被证明能与许多哺乳动物物种中的P170发生反应,并检测到位于质膜胞质面的一个表位。利用MRK16,我们先前已描述了正常人体组织中P170在肝细胞胆小管面、肾近端小管细胞顶端表面以及下消化道表面上皮的定位。在这项工作中,我们报告MRK16在一些人脑样本的毛细血管中也能检测到P170。在大鼠组织中使用单克隆抗体C219也发现了类似的模式。此外,单克隆抗体C219在大鼠和人类组织中选定的骨骼肌纤维和所有心肌纤维中显示出强烈的定位。ATP酶细胞化学显示这些有反应的骨骼肌纤维属于I型(慢肌纤维)。在大鼠组织中,C219反应的其他额外部位见于胰腺腺泡、精囊和睾丸。电泳凝胶免疫印迹显示有两条与单克隆抗体C219反应的蛋白带。在肝脏中,单克隆抗体C219与一条约170 KD的条带发生反应。在骨骼肌和心肌中,单克隆抗体C219与一条约200 KD的条带发生反应,该条带与肌球蛋白在同一位置迁移。这条带也与骨骼肌肌球蛋白抗体发生反应。这一结果表明C219可能与心肌和骨骼肌中的肌肉肌球蛋白重链发生交叉反应。由于单克隆抗体C219能与P170以外的蛋白质发生反应,因此在多药耐药研究中应谨慎使用。